Notice of Application to Register a Trade Name Product (Notice No. MPI 559)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Rotavec Corona
Reference: A8132
Active Ingredients and Concentrations:
Bovine coronavirus (inactivated)
Bovine rotavirus (inactivated)
Escherichia coli K99 (pili)
Formulation Type: Oily solution
General Use Claim:
For the active immunisation of pregnant cows and heifers to raise antibodies against rotavirus, coronavirus and Escherichia coli adhesion F5 (K99) antigen. While the calves are fed colostrum from vaccinated cows during the first two to four weeks of life, these antibodies have been demonstrated to:
Intramuscular Injection: Vaccinate in the anterior third of the neck. Do not vaccinate at other intramuscular sites other than the recommended site.
Subcutaneous Injection: Vaccinate in the caudal tail fold (ischiorectal fossa) or in the anterior third of the neck.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Schering-Plough Animal Health Limited, 33 Whakatiki Street, Upper Hutt 5018. Postal Address: Private Bag 908, Upper Hutt 5140.
Dated at Wellington this 20th day of October 2015.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).